Trial · NCT02267317
Adverse events36
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 36
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Phlebitis Grade 1, 2 or 3 | Vascular disorders | Obese Group - Placebo | 7 | 11 | |
| other | Phlebitis Grade 1, 2 or 3 | Vascular disorders | Obese Group - Eritoran | 9 | 11 | |
| other | Phlebitis Grade 1, 2 or 3 | Vascular disorders | Diabetes (T2DM) Group - Placebo | 1 | 3 | |
| other | Phlebitis Grade 1, 2 or 3 | Vascular disorders | Diabetes (T2DM) Group - Eritoran | 2 | 3 | |
| other | Phlebitis Grade 1, 2 or 3 | Vascular disorders | Lean/Healthy Group - Placebo | 0 | 1 | |
| other | Phlebitis Grade 1, 2 or 3 | Vascular disorders | Lean/Healthy Group - Eritoran | 0 | 1 | |
| other | Dermatology | Skin and subcutaneous tissue disorders | Obese Group - Placebo | 1 | 11 | |
| other | Dermatology | Skin and subcutaneous tissue disorders | Obese Group - Eritoran | 0 | 11 | |
| other | Dermatology | Skin and subcutaneous tissue disorders | Diabetes (T2DM) Group - Placebo | 0 | 3 | |
| other | Dermatology | Skin and subcutaneous tissue disorders | Diabetes (T2DM) Group - Eritoran | 0 | 3 | |
| other | Dermatology | Skin and subcutaneous tissue disorders | Lean/Healthy Group - Placebo | 0 | 1 | |
| other | Dermatology | Skin and subcutaneous tissue disorders | Lean/Healthy Group - Eritoran | 0 | 1 | |
| other | Hot flashes | Reproductive system and breast disorders | Obese Group - Placebo | 0 | 11 | |
| other | Hot flashes | Reproductive system and breast disorders | Obese Group - Eritoran | 1 | 11 | |
| other | Hot flashes | Reproductive system and breast disorders | Diabetes (T2DM) Group - Placebo | 0 | 3 | |
| other | Hot flashes | Reproductive system and breast disorders | Diabetes (T2DM) Group - Eritoran | 0 | 3 | |
| other | Hot flashes | Reproductive system and breast disorders | Lean/Healthy Group - Placebo | 0 | 1 | |
| other | Hot flashes | Reproductive system and breast disorders | Lean/Healthy Group - Eritoran | 0 | 1 | |
| other | Hypokalemia | Blood and lymphatic system disorders | Obese Group - Placebo | 1 | 11 | |
| other | Hypokalemia | Blood and lymphatic system disorders | Obese Group - Eritoran | 0 | 11 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02267317/events